Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1266646.RApcG5F1b6GRBdHZ7ksOdZPMVcfl3cKNN6DvYUkghbRRE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1266646.RApcG5F1b6GRBdHZ7ksOdZPMVcfl3cKNN6DvYUkghbRRE130_assertion type Assertion NP1266646.RApcG5F1b6GRBdHZ7ksOdZPMVcfl3cKNN6DvYUkghbRRE130_head.
- NP1266646.RApcG5F1b6GRBdHZ7ksOdZPMVcfl3cKNN6DvYUkghbRRE130_assertion description "[Thus our preclinical studies show potent activity of CART33 and indicate that transient expression of anti-CD33 CAR by RNA modification could be used in patients to avoid long-term myelosuppression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266646.RApcG5F1b6GRBdHZ7ksOdZPMVcfl3cKNN6DvYUkghbRRE130_provenance.
- NP1266646.RApcG5F1b6GRBdHZ7ksOdZPMVcfl3cKNN6DvYUkghbRRE130_assertion evidence source_evidence_literature NP1266646.RApcG5F1b6GRBdHZ7ksOdZPMVcfl3cKNN6DvYUkghbRRE130_provenance.
- NP1266646.RApcG5F1b6GRBdHZ7ksOdZPMVcfl3cKNN6DvYUkghbRRE130_assertion SIO_000772 25721896 NP1266646.RApcG5F1b6GRBdHZ7ksOdZPMVcfl3cKNN6DvYUkghbRRE130_provenance.
- NP1266646.RApcG5F1b6GRBdHZ7ksOdZPMVcfl3cKNN6DvYUkghbRRE130_assertion wasDerivedFrom befree-2016 NP1266646.RApcG5F1b6GRBdHZ7ksOdZPMVcfl3cKNN6DvYUkghbRRE130_provenance.
- NP1266646.RApcG5F1b6GRBdHZ7ksOdZPMVcfl3cKNN6DvYUkghbRRE130_assertion wasGeneratedBy ECO_0000203 NP1266646.RApcG5F1b6GRBdHZ7ksOdZPMVcfl3cKNN6DvYUkghbRRE130_provenance.